Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders'Equity (Unaudited)

v3.21.2
Condensed Consolidated Statements of Changes in Stockholders'Equity (Unaudited) - USD ($)
$ in Thousands
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Beginning balance, value at Mar. 31, 2020 $ 2 $ 186,559 $ (172,246) $ (5,610) $ 8,705
Beginning balance, shares at Mar. 31, 2020 1.55 1,777,483        
Stock based compensation related to common stock restricted stock grants 18 18
Stock based compensation related to common stock restricted stock grants, shares   3,086        
Stock based compensation, net of forfeitures 45 45
Issuance of common stock due to warrant exercises 1,490 1,490
Issuance of common stock due to warrant exercises, shares   169,167        
Conversion of Series C convertible preferred stock into common stock
Conversion of Series C convertible preferred stock into common stock, shares (1.55) 17,222        
Foreign currency translation adjustment 167 167
Net income 240 240
Ending balance, value at Jun. 30, 2020 $ 2 188,112 (172,006) (5,443) 10,665
Ending balance, shares at Jun. 30, 2020 1,966,958        
Beginning balance, value at Mar. 31, 2021 $ 2 189,217 (179,277) (4,579) 5,363
Beginning balance, shares at Mar. 31, 2021 2,092,909        
Transaction costs related to ATM agreement offering (10) (10)
Employee stock-based compensation expenses 56 56
Stock based compensation related to issuance of common stock restricted 3 3
Foreign currency translation adjustment 307 307
Net income (1,098) (1,098)
Ending balance, value at Jun. 30, 2021 $ 2 $ 189,266 $ (180,375) $ (4,272) $ 4,621
Ending balance, shares at Jun. 30, 2021 2,092,909